vs

Side-by-side financial comparison of AST SpaceMobile, Inc. (ASTS) and Axogen, Inc. (AXGN). Click either name above to swap in a different company.

Axogen, Inc. is the larger business by last-quarter revenue ($61.5M vs $54.3M, roughly 1.1× AST SpaceMobile, Inc.). Over the past eight quarters, AST SpaceMobile, Inc.'s revenue compounded faster (173.4% CAGR vs 13.3%).

AST SpaceMobile, Inc. is a publicly traded satellite designer and manufacturer based in Midland, Texas, United States. The company is building the SpaceMobile satellite constellation, a space-based cellular broadband network designed to connect directly to standard, unmodified smartphones. The network is intended to deliver 4G and 5G broadband coverage globally, particularly in remote and underserved regions.

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering (IPO). Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is...

ASTS vs AXGN — Head-to-Head

Bigger by revenue
AXGN
AXGN
1.1× larger
AXGN
$61.5M
$54.3M
ASTS
Faster 2-yr revenue CAGR
ASTS
ASTS
Annualised
ASTS
173.4%
13.3%
AXGN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ASTS
ASTS
AXGN
AXGN
Revenue
$54.3M
$61.5M
Net Profit
$-19.6M
Gross Margin
75.2%
Operating Margin
-560.4%
20.2%
Net Margin
-31.9%
Revenue YoY
26.6%
Net Profit YoY
-410.8%
EPS (diluted)
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTS
ASTS
AXGN
AXGN
Q1 26
$54.3M
$61.5M
Q4 25
$54.3M
$59.9M
Q3 25
$14.7M
$60.1M
Q2 25
$56.7M
Q1 25
$48.6M
Q4 24
$49.4M
Q3 24
$48.6M
Q2 24
$47.9M
Net Profit
ASTS
ASTS
AXGN
AXGN
Q1 26
$-19.6M
Q4 25
$-74.0M
$-13.2M
Q3 25
$-122.9M
$708.0K
Q2 25
$579.0K
Q1 25
$-3.8M
Q4 24
$450.0K
Q3 24
$-1.9M
Q2 24
$-1.9M
Gross Margin
ASTS
ASTS
AXGN
AXGN
Q1 26
75.2%
Q4 25
74.1%
Q3 25
76.6%
Q2 25
74.2%
Q1 25
71.9%
Q4 24
76.1%
Q3 24
74.9%
Q2 24
73.8%
Operating Margin
ASTS
ASTS
AXGN
AXGN
Q1 26
-560.4%
20.2%
Q4 25
-175.0%
-16.3%
Q3 25
-1109.0%
3.2%
Q2 25
3.0%
Q1 25
-3.4%
Q4 24
4.1%
Q3 24
-0.6%
Q2 24
-0.9%
Net Margin
ASTS
ASTS
AXGN
AXGN
Q1 26
-31.9%
Q4 25
-136.2%
-22.0%
Q3 25
-833.7%
1.2%
Q2 25
1.0%
Q1 25
-7.9%
Q4 24
0.9%
Q3 24
-3.8%
Q2 24
-4.0%
EPS (diluted)
ASTS
ASTS
AXGN
AXGN
Q1 26
$-0.38
Q4 25
$-0.28
Q3 25
$0.01
Q2 25
$0.01
Q1 25
$-0.08
Q4 24
$-0.00
Q3 24
$-0.04
Q2 24
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTS
ASTS
AXGN
AXGN
Cash + ST InvestmentsLiquidity on hand
$2.3B
$82.7M
Total DebtLower is stronger
$12.0M
Stockholders' EquityBook value
$2.4B
$244.8M
Total Assets
$5.0B
$289.5M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTS
ASTS
AXGN
AXGN
Q1 26
$2.3B
$82.7M
Q4 25
$4.3B
$41.5M
Q3 25
$2.4B
$35.8M
Q2 25
$29.9M
Q1 25
$22.1M
Q4 24
$33.5M
Q3 24
$24.5M
Q2 24
$21.1M
Total Debt
ASTS
ASTS
AXGN
AXGN
Q1 26
$12.0M
Q4 25
$48.4M
Q3 25
$48.2M
Q2 25
$47.9M
Q1 25
$47.7M
Q4 24
$47.5M
Q3 24
$47.3M
Q2 24
$47.0M
Stockholders' Equity
ASTS
ASTS
AXGN
AXGN
Q1 26
$2.4B
$244.8M
Q4 25
$2.4B
$128.8M
Q3 25
$1.6B
$120.8M
Q2 25
$112.3M
Q1 25
$105.4M
Q4 24
$103.9M
Q3 24
$99.4M
Q2 24
$95.7M
Total Assets
ASTS
ASTS
AXGN
AXGN
Q1 26
$5.0B
$289.5M
Q4 25
$5.0B
$221.7M
Q3 25
$2.6B
$216.4M
Q2 25
$205.5M
Q1 25
$196.2M
Q4 24
$203.7M
Q3 24
$192.0M
Q2 24
$188.9M
Debt / Equity
ASTS
ASTS
AXGN
AXGN
Q1 26
0.01×
Q4 25
0.38×
Q3 25
0.40×
Q2 25
0.43×
Q1 25
0.45×
Q4 24
0.46×
Q3 24
0.48×
Q2 24
0.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTS
ASTS
AXGN
AXGN
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$-1.4M
FCF MarginFCF / Revenue
-2.3%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTS
ASTS
AXGN
AXGN
Q1 26
Q4 25
$65.0M
$3.0M
Q3 25
$-64.5M
$3.2M
Q2 25
$7.7M
Q1 25
$-13.2M
Q4 24
$8.7M
Q3 24
$3.9M
Q2 24
$4.2M
Free Cash Flow
ASTS
ASTS
AXGN
AXGN
Q1 26
$-1.4M
Q4 25
$-330.7M
$1.8M
Q3 25
$-302.9M
$1.7M
Q2 25
$7.0M
Q1 25
$-13.4M
Q4 24
$8.1M
Q3 24
$3.3M
Q2 24
$3.3M
FCF Margin
ASTS
ASTS
AXGN
AXGN
Q1 26
-2.3%
Q4 25
-609.0%
3.0%
Q3 25
-2055.0%
2.8%
Q2 25
12.4%
Q1 25
-27.7%
Q4 24
16.3%
Q3 24
6.8%
Q2 24
6.8%
Capex Intensity
ASTS
ASTS
AXGN
AXGN
Q1 26
Q4 25
728.7%
2.1%
Q3 25
1617.6%
2.5%
Q2 25
1.3%
Q1 25
0.5%
Q4 24
1.4%
Q3 24
1.2%
Q2 24
1.9%
Cash Conversion
ASTS
ASTS
AXGN
AXGN
Q1 26
Q4 25
Q3 25
4.55×
Q2 25
13.35×
Q1 25
Q4 24
19.41×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons